Construction and Structural Assessment of Nanocapsule Containing HER2-MUC1 Chimeric Protein as a Candidate for a Vaccine Against Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Construction and Structural Assessment of Nanocapsule Containing HER2-MUC1 Chimeric Protein as a Candidate for a Vaccine Against Breast Cancer

Published:2019-05-20 Issue:In Press Volume:In Press Page:
ISSN:2538-4422
Container-title:International Journal of Cancer Management
language:
Short-container-title:Int J Cancer Manag

Author:

Behnaz Nastaran,Zare Karizi Shohreh,Nazarian Shahram,Kazemi Rouhollah,Motamedi Mohammad Javad,Fasihi-Ramandi Mahdi,Amani Jafar

Publisher

Briefland

Subject

Pharmacology (medical),Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference25 articles.

1. Current technologies for HER2 testing in breast cancer

2. MUC1: the polymorphic appearance of a human mucin

3. New Immunoassays for MUC1 in Breast Cancer

4. Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymeric nanoparticles for DNA vaccine-based cancer immunotherapy: a review;Biotechnology Letters;2023-06-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP